FDA Calendar for Alexza Pharmaceuticals, Inc. (ALXA)

| Register (free)
Alexza Pharmaceuticals, Inc. (Alexza) is a pharmaceutical company focused on the research, development, and commercialization of products for the acute treatment of central nervous system (CNS) conditions. The Company’s product candidates are based on its technology, the Staccato system. The Staccato system vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for systemic drug delivery. Alexza has five other product candidates in various stages of clinical development. On August 26, 2009, Alexza completed the acquisition of Symphony Allegro, Inc.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
AZ-004 Other Pending DecisionNDA
AZ-001 Pain Management UnknownPhase 2
AZ-104 Pain Management UnknownPhase 2
AZ-003 Pain Management UnknownPhase 1
AZ-002 Other UnknownPhase 2
AZ-007 Other UnknownPhase 1


Events

No future events listed at this time, please check back later.
5 past event(s) found. Click here to view them.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

ALXA

$0.76
-0.025 -3.21%
2/3/2012 4:00:00 PM

Sponsors

Other Links